Tirzepatide becoming a dual GLP-1 and GIP agonist, it is actually suggested which the GIP component of dual agonism may very well be liable for the extra gain, specified the possible benefit of GIP receptor agonism on peripheral insulin sensitization. Therefore, tirzepatide was simpler than dulaglutide in cutting down fasting dietary TAG [6,seven]